VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CGCCanopy Growth Corporation
$0.95$364M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCGCFinancials

Canopy Growth Corporation (CGC) Financials

17Y historyFree accessUpdated daily

Revenue growth remains highly volatile with quarterly fluctuations, while gross margins have compressed significantly to 11.6% in 2025Q4 from a 36.0% peak in 2023Q3.

CGC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricMar'26Mar'25Mar'24Mar'23Mar'22Mar'21Mar'20Mar'19Mar'18Mar'17Mar'16Dec'14Dec'13Jul'13Jul'12Jul'11Jul'10
Sales/Revenue284.6M269M297.15M333.25M475.7M546.65M398.77M226.34M77.95M39.9M12.7M1.9M04.14K4.76K4.49K549
Revenue Growth %5.8%-9.47%-10.83%-29.94%-12.98%37.08%76.18%190.37%95.38%214.16%569.5%--100%-13%6.13%717.49%-
Cost of Goods Sold214.93M189.48M216.26M396.78M663.11M479.69M430.46M137.41M3.76M2.26M-6.29M731.31K00000
COGS % of Revenue75.52%70.44%72.78%119.06%139.4%87.75%107.95%60.71%4.82%5.67%-49.51%38.56%-----
Gross Profit69.67M79.51M80.88M-63.53M-187.41M66.96M-31.68M88.93M74.19M38.71M18.99M414.35K04.14K04.49K549
Gross Margin %24.48%29.56%27.22%-19.06%-39.4%12.25%-7.95%39.29%95.18%97.04%149.51%21.84%-100%-100%100%
Gross Profit Growth %-12.38%-1.7%227.32%66.1%-379.89%311.34%-135.63%19.86%91.64%103.91%4482.13%--100%--100%717.49%-
Operating Expenses142.78M196.65M309.6M2.57B831.38M1.31B1.64B642.58M153.07M52.8M21.73M8.15M931.66K68.75K26.16K28.56K27.47K
OpEx % of Revenue50.17%73.11%104.19%770.28%174.77%239.72%410.58%283.9%196.37%132.34%171.16%429.75%-1659.07%549.15%636.27%5003.1%
Selling, General & Admin122.92M121.71M180.59M297.98M361.1M523.85M867.74M605.83M131.13M38.55M17.33M7.99M931.66K68.75K26.16K28.56K27.47K
SG&A % of Revenue43.19%45.25%60.77%89.41%75.91%95.83%217.6%267.66%168.22%96.64%136.44%421.33%-1659.07%549.15%636.27%5003.1%
Research & Development01.91M4.61M21.72M32.26M57.58M61.81M15.24M1.45M810K721K159.65K00000
R&D % of Revenue-0.71%1.55%6.52%6.78%10.53%15.5%6.73%1.86%2.03%5.68%8.42%-----
Other Operating Expenses19.85M74.95M124.39M2.25B438.03M728.99M707.73M21.51M20.49M13.43M3.69M000000
Operating Income-73.11M-117.14M-228.71M-2.63B-1.02B-1.24B-1.67B-615.21M-107.77M-14.08M-2.75M-6.56M-931.66K-64.61K-21.39K-19.58K-26.92K
Operating Margin %-25.69%-43.55%-76.97%-789.34%-214.17%-227.47%-418.53%-271.81%-138.26%-35.3%-21.65%-346.1%--1559.07%-449.15%-436.27%-4903.1%
Operating Income Growth %37.59%48.78%91.31%-158.2%18.07%25.5%-171.28%-470.84%-665.27%-412.3%58.13%-604.64%-1342.01%-202.01%-9.26%27.26%-
EBITDA-36.63M-74.03M-175.54M-2.55B-907.86M-1.12B-1.54B-568.29M-87.29M-8.02M-493K-6.06M-927.47K-64.61K-21.39K-19.58K-26.92K
EBITDA Margin %-12.87%-27.52%-59.07%-765.33%-190.85%-204.21%-387.18%-251.08%-111.98%-20.1%-3.88%-319.36%--1559.07%-449.15%-436.27%-4903.1%
EBITDA Growth %50.51%57.83%93.12%-180.93%18.68%27.7%-171.68%-551.06%-988.5%-1526.57%91.86%-553.13%-1335.54%-202.01%-9.26%27.26%-
D&A (Non-Cash Add-back)36.47M43.12M53.18M80.03M110.94M127.12M125.01M46.92M20.49M6.06M2.26M507.2K4.19K0000
EBIT-224.69M-522.43M-366M-2.96B-163.92M-576.77M-1.5B-614.06M-116.19M-6.71M-1.32M-6.56M-931.66K-64.61K-21.39K-19.58K-26.92K
Net Interest Income-28.2M-65.75M-89.12M-101.88M-97.34M12.91M59.61M30.9M566K-66K-140K40.55K004.76K0549
Interest Income10M8.81M16.23M24.28M6.6M21.37M66.33M49.31M1.35M0040.55K004.76K4.49K549
Interest Expense38.19M74.57M105.35M126.16M103.94M8.46M6.72M18.41M784K66K140K01.27K004.49K0
Other Income/Expense-189.78M-479.85M-242.64M-455.64M750.94M-440.5M159.91M-94.03M68.14M3.81M-621K-912.37K-1.27K00026.92K
Pretax Income-262.88M-597M-471.36M-3.09B-267.86M-1.68B-1.51B-709.24M-51.46M-10.28M-3.37M-7.48M-932.92K-64.61K-21.39K00
Pretax Margin %-92.37%-221.94%-158.63%-926.07%-56.31%-308.05%-378.43%-313.35%-66.01%-25.76%-26.54%-394.18%--1559.07%-449.15%--
Income Tax23K7.14M12.33M-5.73M-8.95M-13.14M-121.61M4.11M-392K2.7M126K0000-4.49K26.92K
Effective Tax Rate %-0.01%-1.2%-2.62%0.19%3.34%0.78%8.06%-0.58%0.76%-26.31%-3.74%0%0%0%0%--
Net Income-262.91M-598.12M-657.27M-3.28B-310.04M-1.74B-1.32B-736.28M-67.28M-7.52M-3.5M-8.93M-932.92K-64.61K-21.39K-24.07K-26.92K
Net Margin %-92.38%-222.35%-221.19%-983.68%-65.18%-319.2%-331.35%-325.3%-86.32%-18.85%-27.53%-470.87%--1559.07%-449.15%-536.27%-4903.1%
Net Income Growth %56.04%9%79.95%-957.32%82.23%-32.06%-79.46%-994.3%-794.6%-115.13%60.86%-857.35%-1343.98%-202.01%11.11%10.59%-
Net Income (Continuing)-262.91M-604.14M-483.68M-3.08B-258.91M-1.67B-1.39B-712.02M-51.06M-7.57M-3.5M-8.93M-932.92K-64.61K-21.39K-24.07K-26.92K
Discontinued Operations06.02M-192.11M-229.12M-71.66M000000000000
Minority Interest00139K1.59M36.84M140.01M204.8M289.81M84.47M-32K0000000
EPS (Diluted)-0.88-5.53-8.79-70.70-7.70-4.45-3.90-1.99-0.31-0.14-0.05-0.30-0.93-0.06-0.02-0.02-0.03
EPS Growth %84.09%37.09%87.57%-818.18%-73.03%-14.1%-95.98%-541.94%-121.43%-208.37%84.87%67.74%-1341.86%-201.4%11.2%10.41%-
EPS (Basic)-0.88-5.53-6.47-70.70-7.70-4.45-3.96-1.99-0.31-0.14-0.05-0.30-0.93-0.06-0.02-0.02-0.03
Diluted Shares Outstanding2.98B107.55M74.79M46.37M39.13M375.71M356.15M337.51M177.3M118.99M77.02M29.95M1M1M1M1M1M
Basic Shares Outstanding2.98B107.55M101.63M46.37M39.13M375.28M350.03M337.51M177.3M118.99M77.02M29.95M1M1M1M1M1M
Dividend Payout Ratio-----------------

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Regulatory and liquidity constraints

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2025Q4)

Revenue Growth Remains Highly Volatile

As indicated by recent financial disclosures, CGC's top-line performance exhibits significant quarterly variance, with revenue fluctuating from a high of $102.3 million in 2025Q3 to $65.0 million in 2024Q4, suggesting that organic growth durability remains elusive amidst ongoing shifts in the Canadian recreational cannabis market.

The inconsistent revenue trajectory appears to reflect the company's struggle to maintain market share in a commoditized environment. Investors should monitor whether the recent pivot toward an asset-light model can stabilize these top-line swings or if competitive pricing pressures will continue to dictate the company's growth ceiling.

Gross Margin Volatility Reflects Instability

According to reported income statements, gross margins have oscillated significantly, dropping to 11.6% in 2025Q4 from a peak of 36.0% in 2023Q3, which highlights the structural difficulty in maintaining pricing power while navigating the heavy excise tax burden inherent in the Canadian cannabis sector.

The compression of margins suggests that the company's product mix may be shifting toward lower-margin categories or that aggressive discounting is required to move inventory. This instability warrants further investigation into whether the Storz & Bickel hardware segment can provide the necessary margin floor to offset cannabis-related volatility.

Operating Leverage Remains Severely Constrained

Based on the provided quarterly data, operating expenses consistently exceed gross profit, resulting in persistent operating losses that reached $27.5 million in 2025Q4, indicating that the company has yet to achieve the necessary scale to cover its fixed overhead and administrative cost structure.

The inability to scale operating income faster than gross profit suggests that the current cost-cutting initiatives have not yet reached a critical mass. Analysts should remain cautious, as the persistent gap between gross profit and SG&A expenses implies that the business model remains fundamentally reliant on external capital.

Net Income Obscured by Volatility

As reported in financial filings, net income figures are frequently distorted by large, non-recurring charges, including a $157.1 million loss in 2025Q4, which complicates the assessment of core operational performance and suggests that reported EPS is not a reliable indicator of underlying business health.

The frequent, large-scale write-downs and non-operating items suggest that the company's bottom line is highly sensitive to accounting adjustments rather than operational efficiency. Investors should focus on cash-based metrics to better understand the true economic reality of the firm's ongoing operations.

Structural Risks to Solvency Persist

Based on the historical trend of negative net income and persistent cash burn, the company's reliance on equity issuance to fund operations appears to be a primary concern, as evidenced by the recurring dilution and the ongoing need to manage debt obligations in a high-rate environment.

Short-sellers may focus on the company's limited cash runway and the potential for further dilutive financing if the asset-light transition fails to yield positive cash flow. The structural separation of U.S. assets further complicates the valuation, potentially masking the true extent of the capital required to sustain the enterprise.

CGC — Frequently Asked Questions

Quick answers to the most common questions about buying CGC stock.

What was Canopy Growth Corporation's (CGC) revenue in 2025?

For fiscal year 2025, Canopy Growth Corporation (CGC) reported total revenue of $284.6M. This represents a 51840155.0% increase compared to $0.0M in 2009.

Is Canopy Growth Corporation (CGC) profitable?

Canopy Growth Corporation (CGC) reported a net loss of $262.9M for the fiscal year ending 2025.

What is Canopy Growth Corporation's operating profit margin?

Canopy Growth Corporation (CGC) reported an operating income of $-73.1M, resulting in an operating profit margin of -25.7%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Canopy Growth Corporation's gross profit and gross margin?

Canopy Growth Corporation (CGC) generated $69.7M in gross profit for the year, representing a gross profit margin of 24.5%. This demonstrates the company's core pricing power and production efficiency.